Development and Validation of Reagents and Assays for EZH2 Peptide and Nucleosome High-Throughput Screens
暂无分享,去创建一个
S. Thrall | G. Hofmann | L. Lafrance | M. Pappalardi | Baochau Le | M. T. McCabe | R. Kruger | Yong Jiang | S. Sweitzer | Zining Wu | A. Pope | G. V. Van Aller | P. Tummino | C. Creasy | S. Verma | Elsie Diaz | M. Brandt | Mehul P. Patel | B. Schwartz | Stephanie Chen | Carl A. Machutta | C. Nixon | Danielle Key | Sharon M. Sweitzer
[1] Yong Jiang,et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) , 2012, Proceedings of the National Academy of Sciences.
[2] S. Thrall,et al. Methyltransferases prefer monomer over core-trimmed nucleosomes as in vitro substrates. , 2011, Analytical biochemistry.
[3] V. Schramm,et al. Characterizing DNA methyltransferases with an ultrasensitive luciferase-linked continuous assay. , 2011, Analytical chemistry.
[4] H. Al‐Hashimi,et al. Direct Evidence for Methyl Group Coordination by Carbon-Oxygen Hydrogen Bonds in the Lysine Methyltransferase SET7/9* , 2011, The Journal of Biological Chemistry.
[5] Ryan D. Morin,et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. , 2011, Blood.
[6] D. Reinberg,et al. The Polycomb complex PRC2 and its mark in life , 2011, Nature.
[7] Chad Quinn,et al. Assay Development and High-Throughput Screening of Small Molecular c-Abl Kinase Activators , 2011, Journal of biomolecular screening.
[8] R. Copeland,et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.
[9] E. Hurt,et al. Clinical significance of Polycomb gene expression in brain tumors , 2010, Molecular Cancer.
[10] James R. Brown,et al. Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.
[11] Anton Simeonov,et al. A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors. , 2010, Molecular bioSystems.
[12] Lily Wu,et al. Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines , 2010, The Prostate.
[13] K. Helin,et al. Histone methyltransferases in cancer. , 2010, Seminars in cell & developmental biology.
[14] D. Reinberg,et al. Chromatin structure and the inheritance of epigenetic information , 2010, Nature Reviews Genetics.
[15] J. Hevel,et al. A fast and efficient method for quantitative measurement of S-adenosyl-L-methionine-dependent methyltransferase activity with protein substrates. , 2010, Analytical biochemistry.
[16] R. Klose,et al. Histone lysine methylation: an epigenetic modification? , 2010, Epigenomics.
[17] D. Reinberg,et al. Role of the polycomb protein EED in the propagation of repressive histone marks , 2009, Nature.
[18] Emilia Dimitrova,et al. A Continuous Protein Methyltransferase (G9a) Assay for Enzyme Activity Measurement and Inhibitor Screening , 2009, Journal of biomolecular screening.
[19] Christodoulos A Floudas,et al. High Throughput Characterization of Combinatorial Histone Codes* , 2009, Molecular & Cellular Proteomics.
[20] I. Kariv,et al. A Simplified Scintillation Proximity Assay for Fatty Acid Synthase Activity: Development and Comparison with Other FAS Activity Assays , 2009, Journal of biomolecular screening.
[21] A. Shilatifard,et al. An operational definition of epigenetics. , 2009, Genes & development.
[22] Gavin Harper,et al. Process Validation and Screen Reproducibility in High-Throughput Screening , 2009, Journal of biomolecular screening.
[23] Isabel Coma,et al. Statistics and decision making in high-throughput screening. , 2009, Methods in molecular biology.
[24] R. Trievel,et al. Structural origins for the product specificity of SET domain protein methyltransferases , 2008, Proceedings of the National Academy of Sciences.
[25] V. Bilim,et al. Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2 , 2008, Clinical Cancer Research.
[26] J Fraser Glickman,et al. Scintillation proximity assays in high-throughput screening. , 2008, Assay and drug development technologies.
[27] Ted M. Lakowski,et al. A Kinetic Study of Human Protein Arginine N-Methyltransferase 6 Reveals a Distributive Mechanism* , 2008, Journal of Biological Chemistry.
[28] D. Reinberg,et al. Ezh2 Requires PHF1 To Efficiently Catalyze H3 Lysine 27 Trimethylation In Vivo , 2008, Molecular and Cellular Biology.
[29] R. Trievel,et al. Kinetic manifestation of processivity during multiple methylations catalyzed by SET domain protein methyltransferases. , 2007, Biochemistry.
[30] D. Wasilko,et al. TIPS: Titerless Infected-Cells Preservation and Scale-Up , 2006 .
[31] Johan Eide,et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] Stephen A Boorjian,et al. Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder , 2005, Clinical Cancer Research.
[33] Cyrus Martin,et al. The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.
[34] S. Jacobsen,et al. Substrate Specificity and Kinetic Mechanism of Mammalian G9a Histone H3 Methyltransferase* , 2004, Journal of Biological Chemistry.
[35] Paul Tempst,et al. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. , 2004, Molecular cell.
[36] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] Geoff Kelly,et al. Structure and catalytic mechanism of the human histone methyltransferase SET7/9 , 2003, Nature.
[38] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[39] G. Schnitzler. Isolation of Histones and Nucleosome Cores from Mammalian Cells , 2000, Current protocols in molecular biology.
[40] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.